LTRN
Lantern Pharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.39
-0.14 ▼ -5.53%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$2.41
+0.02 ▲ +0.84%
| Index | - | P/E | - | EPS (ttm) | -1.75 | Insider Own | 22.18% | Shs Outstand | 0.01B | Perf Week | -11.48% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | -14.37% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -16.14% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.46 | Inst Own | 11.36% | Short Float | 3.77% | Perf Quarter | -37.43% |
| Income | -0.02B | P/S | - | EPS this Y | 13.47% | Inst Trans | 0.09% | Short Ratio | 6.03 | Perf Half Y | -39.19% |
| Sales | 0.00B | P/B | 2.75 | EPS next 5Y | -1.53% | ROA | -86.16% | Short Interest | 0.33M | Perf YTD | -21.12% |
| Book/sh | 0.87 | P/C | 2.16 | EPS past 3/5Y | -19.42% -37.87% | ROE | -104.58% | 52W High | -58.39% ($5.74) | Perf Year | -36.1% |
| Cash/sh | 1.11 | P/FCF | - | Sales past 3/5Y | - | ROIC | -197.36% | 52W Low | -2.45% ($2.45) | Perf 3Y | -49.15% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 1.18% | Gross Margin | - | Volatility(W/M) | 6.83% 7.89% | Perf 5Y | -87.4% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.21 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.33 | EPS Q/Q | 7.88% | Profit Margin | - | RSI (14) | 33.59 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.33 | Sales Q/Q | - | SMA20 | -11.55% ($2.7) | Beta | 1.54 | Target Price | $22.67 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | -20.21% ($3) | Rel Volume | 1.12 | Prev Close | $2.53 |
| Employees | 24 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 17.02% - | SMA200 | -34.13% ($3.63) | Avg Volume(3M) | 0.05M | Price | $2.39 |
| IPO | 2020/6/11 | Option/Short | Yes/Yes | Trades | 586 | Volume | 61,026 | Change | -5.53% |
뉴스 로딩 중...